Chargement de la fiche…
rhumatologie
Dr Charles Molta
Lupus · Anti-TNF · SAPL
0Publications
0Citations de la publi la +
Côté patient
Avant votre rendez-vous avec le Dr Charles Molta
Choisissez votre pathologie pour une explication en langage simple.
Parcourir toutes les pathologies →Des applications évaluées par MonRhumato, sélectionnées pour les patients.
MapathoPlateforme communautaire maladies chroniques + annuaire pair-validé
GustaveAgent IA souverain pour information patient sourcée
Remedee LabsBracelet stimulateur d'endorphines pour douleur chroniquePourquoi consulter Dr Charles Molta
- Auteur de référence en rhumatologie
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
Dernières publications
Publications les plus citées
178 citationsComparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial2010 · BMJ (Clinical research ed.)PubMed ↗96 citationsResponse to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA2016 · Lupus science & medicinePubMed ↗81 citationsBurden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States2014 · Arthritis care & researchPubMed ↗
Diplômes & qualifications
DES
Rhumatologie (SM) — Diplôme d'Études Spécialisées
CES
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
Lieu d'exercice
localisation non renseignée
Domaines d'expertise
LupusAnti-TNFSAPLRevue généraleVascularites
Lupus
152017Lupus science & medicine
PubMed ↗Presentation of SLE in UK primary care using the Clinical Practice Research Datalink
2016Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
2016Lupus
PubMed ↗Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care
2016Lupus
PubMed ↗Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab
2016Clinical therapeutics
PubMed ↗Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus
2016Lupus science & medicine
PubMed ↗Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA
2014Lupus
PubMed ↗Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel
2014Rheumatic diseases clinics of North America
PubMed ↗Post-marketing experiences with belimumab in the treatment of SLE patients
2014Arthritis care & research
PubMed ↗Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States
2013Clinical therapeutics
PubMed ↗Cumulative burden of oral corticosteroid adverse effects and the economic implications of corticosteroid use in patients with systemic lupus erythematosus
2013Journal of medical economics
PubMed ↗A longitudinal analysis of costs associated with change in disease activity in systemic lupus erythematosus
2013BioMed research international
PubMed ↗Healthcare utilization and costs of systemic lupus erythematosus in Medicaid
1993Pediatrics
PubMed ↗Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives
1992Contributions to nephrology
PubMed ↗Antiphospholipid antibodies in patients with childhood onset systemic lupus erythematosus and their relatives. A French cooperative study
1990Revue du rhumatisme et des maladies osteo-articulaires
PubMed ↗[Profile of antinuclear antibodies in 14 cases of extinct systemic lupus erythematosus for more than 3 years]
Anti-TNF
32012Journal of the European Academy of Dermatology and Venereology : JEADV
PubMed ↗Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens
2011Journal of the European Academy of Dermatology and Venereology : JEADV
PubMed ↗Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial
2010BMJ (Clinical research ed.)
PubMed ↗Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial
SAPL
21993Pediatrics
PubMed ↗Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives
1992Contributions to nephrology
PubMed ↗Antiphospholipid antibodies in patients with childhood onset systemic lupus erythematosus and their relatives. A French cooperative study
Transversal
22013The Journal of dermatological treatment
PubMed ↗Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study
2012Annals of the rheumatic diseases
PubMed ↗Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set
Revue générale
11989Clinical and experimental rheumatology
PubMed ↗Familial occurrence of systemic sclerosis, rheumatoid arthritis and other immunological disorders: report of two kindreds with study of HLA antigens and review of the literature
Vascularites
12000The Journal of rheumatology
PubMed ↗Wegener's granulomatosis: pitfalls in the management of pulmonary disease: A case of Wegener's granulomatosis with a hilar mass
Données issues de l'Annuaire Santé (ANS) — Licence Ouverte 2.0. Enrichissements à partir de sources publiques. Vous êtes le praticien référencé ? Faites corriger ou retirer votre fiche : demande de rectification ou de retrait.